For: | Nonaka M, Morimoto S. Experimental models of inherited cardiomyopathy and its therapeutics. World J Cardiol 2014; 6(12): 1245-1251 [PMID: 25548614 DOI: 10.4330/wjc.v6.i12.1245] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v6/i12/1245.htm |
Number | Citing Articles |
1 |
Sarah A. Dick, Slava Epelman. Chronic Heart Failure and Inflammation. Circulation Research 2016; 119(1): 159 doi: 10.1161/CIRCRESAHA.116.308030
|
2 |
Chen-Ching Yuan, Katarzyna Kazmierczak, Jingsheng Liang, Zhiqun Zhou, Sunil Yadav, Aldrin V. Gomes, Thomas C. Irving, Danuta Szczesna-Cordary.
Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified
MYL2
mice
. Proceedings of the National Academy of Sciences 2018; 115(10) doi: 10.1073/pnas.1716925115
|
3 |
Fernando Pierin Peres-Filho, Suelen Umbelino da Silva, Fernando Pierin Peres, Leandra Ernst Kerche. Heart Failure Treatment with SGLT2 Inhibitors: A Systematic Review with Meta-Analysis. ABC Heart Fail Cardiomyop 2024; 4(4) doi: 10.36660/abchf.20240060i
|
4 |
Fernando Pierin Peres-Filho, Suelen Umbelino da Silva, Fernando Pierin Peres, Leandra Ernst Kerche. Tratamento da Insuficiência Cardíaca com Inibidores de SGLT2: Uma Revisão Sistemática com Metanálise. ABC Heart Failure & Cardiomyopathy 2024; 4(4) doi: 10.36660/abchf.20240060
|
5 |
|
6 |
Brian R. Thompson, Michelle L. Asp, Joseph M. Metzger. Congestive Heart Failure and Cardiac Transplantation. 2017; : 151 doi: 10.1007/978-3-319-44577-9_10
|
7 |
Christopher T. Pappas, Rachel M. Mayfield, Christine Henderson, Nima Jamilpour, Cathleen Cover, Zachary Hernandez, Kirk R. Hutchinson, Miensheng Chu, Ki-Hwan Nam, Jose M. Valdez, Pak Kin Wong, Henk L. Granzier, Carol C. Gregorio. Knockout of Lmod2 results in shorter thin filaments followed by dilated cardiomyopathy and juvenile lethality. Proceedings of the National Academy of Sciences 2015; 112(44): 13573 doi: 10.1073/pnas.1508273112
|
8 |
Timothy J. Cashman, Rebecca Josowitz, Bryce V. Johnson, Bruce D. Gelb, Kevin D. Costa, Vincenzo Lionetti. Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy. PLOS ONE 2016; 11(1): e0146697 doi: 10.1371/journal.pone.0146697
|
9 |
Yuanyuan Dai, Nadezda Ignatyeva, Hang Xu, Ruheen Wali, Karl Toischer, Sören Brandenburg, Christof Lenz, Julius Pronto, Funsho E. Fakuade, Samuel Sossalla, Elisabeth M. Zeisberg, Andreas Janshoff, Ingo Kutschka, Niels Voigt, Henning Urlaub, Torsten Bloch Rasmussen, Jens Mogensen, Stephan E. Lehnart, Gerd Hasenfuss, Antje Ebert. An Alternative Mechanism of Subcellular Iron Uptake Deficiency in Cardiomyocytes. Circulation Research 2023; 133(2) doi: 10.1161/CIRCRESAHA.122.321157
|
10 |
Tarek Khedro, Jason M. Duran, Eric D. Adler. Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells. Current Cardiology Reports 2022; 24(6): 631 doi: 10.1007/s11886-022-01683-8
|
11 |
Francesca Girolami, Giulia Frisso, Matteo Benelli, Lia Crotti, Maria Iascone, Ruggiero Mango, Cristina Mazzaccara, Kalliope Pilichou, Eloisa Arbustini, Benedetta Tomberli, Giuseppe Limongelli, Cristina Basso, Iacopo Olivotto. Contemporary genetic testing in inherited cardiac disease. Journal of Cardiovascular Medicine 2018; 19(1): 1 doi: 10.2459/JCM.0000000000000589
|
12 |
Xin-Yi Wu, Yee-Ki Lee, Yee-Man Lau, Ka-Wing Au, Yiu-Lam Tse, Kwong-Man Ng, Chun-Ka Wong, Hung-Fat Tse. The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal Models. Pharmaceuticals 2024; 17(8): 1030 doi: 10.3390/ph17081030
|